Hongkong Curegene Innovation Co., Limited

This phase 1 trial tests CG-0416, an experimental oral drug that targets thyroid hormone receptors in the liver, in healthy volunteers who are overweight or have obesity. The study aims to evaluate the drug's safety, tolerability, and how the body processes it after single and mu…